Stereotaxis to Present at Three Investor Conferences in March
Cowen and Company40th Annual Health Care Conference Mr. Fischelwill present an overview of Stereotaxisbusiness on Monday, March 2, 2020, 4:50 - 5:20 pm EST, will participate in a breakout session immediately afterwards, and will be available that day for one-on-one meetings.
- Oppenheimer 30th Annual Healthcare Conference
Mr. Fischelwill present an overview of Stereotaxisbusiness on Tuesday, March 17, 2020from 4:30 - 5:00 pm EST, and will be available that day for one-on-one meetings.
- BTIG MedTech,
Digital Health, Life Science & Diagnostic Tools Conference Mr. Fischelwill be available for one-on-one meetings with investors on Wednesday, March 18, 2020.
“We appreciate the invitations to these conferences and look forward to sharing with the investment community Stereotaxis’ differentiated technology, clinical value, and growth strategy.” says
This press release includes statements that may constitute "forward-looking" statements usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in
Chairman and Chief Executive Officer
Chief Financial Officer
Source: Stereotaxis, Inc.